NCT04598919: A reported trial by National Jewish Health
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04598919 |
|---|---|
| Title | Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 12, 2020 |
| Completion date | Sept. 15, 2024 |
| Required reporting date | Sept. 15, 2025, midnight |
| Actual reporting date | Aug. 6, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |